Arteriovenous malformations (AVMs) are a rare but serious medical condition that affects the blood vessels in the body. AVMs can occur in various parts of the body, including the brain, liver, and lungs. When left untreated, AVMs can cause serious health problems, including seizures, bleeding, and even death. However, with advancements in medical technology, AVMs can be treated using liquid embolic agents.
Liquid embolic agents are substances that can be injected into the blood vessels to block blood flow and shrink AVMs. These agents work by causing the blood vessels to clot, cutting off the blood supply to the AVM. The use of liquid embolic agents is a minimally invasive procedure that avoids the need for open surgery, reducing the risk of complications.
The safety and effectiveness of liquid embolic agent embolization of AVMs have been extensively studied and have been found to be highly effective in treating this condition. According to a study published in the Journal of Neurosurgery, embolization with liquid embolic agents was successful in completely occluding the AVM in 45% of cases, and partial occlusion was achieved in 41% of cases. The success rate of embolization increased in case the AVM was located in a deep-laid area, providing a safe treatment approach as it avoids the need for a surgical intervention.
Similarly, LavaTM liquid embolic system on clinical trial highlighted the effectiveness in the treatment of AVMs. The clinical test showed a high success rate with Lava embolization, with no serious complications from doctor's feedback. Lava liquid embolization agent has been shown to be particularly effective in the treatment of brain AVMs.
In addition to its effectiveness, liquid embolic agent embolization of AVMs is also a safe procedure. The risk of complications is low, with minor complications such as headache, nausea, and vomiting being the most common side effects. However, serious complications such as stroke or bleeding are rare and occur in less than 5% of cases, mostly in larger volume AVMs.
Overall, liquid embolic agent embolization is a safe and effective treatment option for AVMs, enabling patients to avoid open surgery and alleviate symptoms of the condition. With the advancements in medical technology, this procedure is becoming more widely available and accessible to patients, allowing them to receive the treatment they need to improve their quality of life. As such, it is essential that medical professionals continue to explore and refine the use of liquid embolic agents to ensure safe, effective, and non-invasive treatment options for patients diagnosed with AVMs.